157 related articles for article (PubMed ID: 18763019)
1. Methylation-specific multiplex ligation-dependent probe amplification in meningiomas.
Ewald C; Hofmann T; Kuhn SA; Deufel T; Beetz C; Kalff R
J Neurooncol; 2008 Dec; 90(3):267-73. PubMed ID: 18763019
[TBL] [Abstract][Full Text] [Related]
2. Methylation-specific multiplex ligation-dependent probe amplification and its impact on clinical findings in medulloblastoma.
Feierabend D; Walter J; Grube S; Herbold C; Beetz C; Kalff R; Ewald C
J Neurooncol; 2014 Jan; 116(2):213-20. PubMed ID: 24162828
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
5. Molecular diagnosis of Prader-Willi and Angelman syndromes by methylation-specific melting analysis and methylation-specific multiplex ligation-dependent probe amplification.
Procter M; Chou LS; Tang W; Jama M; Mao R
Clin Chem; 2006 Jul; 52(7):1276-83. PubMed ID: 16690734
[TBL] [Abstract][Full Text] [Related]
6. Methylation-specific multiplex ligation-dependent probe amplification analysis of subjects with chromosome 15 abnormalities.
Bittel DC; Kibiryeva N; Butler MG
Genet Test; 2007; 11(4):467-75. PubMed ID: 18294067
[TBL] [Abstract][Full Text] [Related]
7. Genome profiling of melanocytic tumors using multiplex ligation-dependent probe amplification (MLPA): Its usefulness as an adjunctive diagnostic tool for melanocytic tumors.
Takata M; Suzuki T; Ansai S; Kimura T; Shirasaki F; Hatta N; Saida T
J Dermatol Sci; 2005 Oct; 40(1):51-7. PubMed ID: 16054806
[TBL] [Abstract][Full Text] [Related]
8. Meningioma showing VHL gene inactivation in a patient with von Hippel-Lindau disease.
Kanno H; Yamamoto I; Yoshida M; Kitamura H
Neurology; 2003 Apr; 60(7):1197-9. PubMed ID: 12682336
[TBL] [Abstract][Full Text] [Related]
9. Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences.
Nygren AO; Ameziane N; Duarte HM; Vijzelaar RN; Waisfisz Q; Hess CJ; Schouten JP; Errami A
Nucleic Acids Res; 2005 Aug; 33(14):e128. PubMed ID: 16106041
[TBL] [Abstract][Full Text] [Related]
10. MGMT methylation assessment in glioblastoma: MS-MLPA versus human methylation 450K beadchip array and immunohistochemistry.
Trabelsi S; Mama N; Ladib M; Karmeni N; Haddaji Mastouri M; Chourabi M; Mokni M; Tlili K; Krifa H; Yacoubi MT; Saad A; H'mida Ben Brahim D
Clin Transl Oncol; 2016 Apr; 18(4):391-7. PubMed ID: 26289551
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous analysis of the methylation profile of 26 cancer related regions in invasive breast carcinomas by MS-MLPA and drMS-MLPA.
Marzese DM; Gago FE; Vargas-Roig LM; Roqué M
Mol Cell Probes; 2010 Oct; 24(5):271-80. PubMed ID: 20561583
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic changes underlie the aggressiveness of histologically benign meningiomas that recur.
San-Miguel T; Navarro L; Megías J; Muñoz-Hidalgo L; Gil-Benso R; Roldán P; López-Ginés C; Cerdá-Nicolás M
Hum Pathol; 2019 Feb; 84():105-114. PubMed ID: 30261191
[TBL] [Abstract][Full Text] [Related]
13. Genetic Analysis Reveals the Important Role of the
Lai YC; Wang WC
Anticancer Res; 2021 Sep; 41(9):4295-4304. PubMed ID: 34475049
[TBL] [Abstract][Full Text] [Related]
14. Development of a multiplex ligation-dependent probe amplification (MLPA) assay for quantification of the OCRL1 gene.
Coutton C; Monnier N; Rendu J; Lunardi J
Clin Biochem; 2010 Apr; 43(6):609-14. PubMed ID: 20043897
[TBL] [Abstract][Full Text] [Related]
15. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
Prowse AH; Webster AR; Richards FM; Richard S; Olschwang S; Resche F; Affara NA; Maher ER
Am J Hum Genet; 1997 Apr; 60(4):765-71. PubMed ID: 9106522
[TBL] [Abstract][Full Text] [Related]
16. Multiplex ligation-dependent probe amplification (MLPA) in tumor diagnostics and prognostics.
Hömig-Hölzel C; Savola S
Diagn Mol Pathol; 2012 Dec; 21(4):189-206. PubMed ID: 23111197
[TBL] [Abstract][Full Text] [Related]
17. Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification.
Hes FJ; van der Luijt RB; Janssen AL; Zewald RA; de Jong GJ; Lenders JW; Links TP; Luyten GP; Sijmons RH; Eussen HJ; Halley DJ; Lips CJ; Pearson PL; van den Ouweland AM; Majoor-Krakauer DF
Clin Genet; 2007 Aug; 72(2):122-9. PubMed ID: 17661816
[TBL] [Abstract][Full Text] [Related]
18. Detailed analysis of 22q11.2 with a high density MLPA probe set.
Jalali GR; Vorstman JA; Errami A; Vijzelaar R; Biegel J; Shaikh T; Emanuel BS
Hum Mutat; 2008 Mar; 29(3):433-40. PubMed ID: 18033723
[TBL] [Abstract][Full Text] [Related]
19. Genomic profiling of cell-free DNA in blood and bone marrow of prostate cancer patients.
Schwarzenbach H; Chun FK; Isbarn H; Huland H; Pantel K
J Cancer Res Clin Oncol; 2011 May; 137(5):811-9. PubMed ID: 20683729
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer.
Banks RE; Tirukonda P; Taylor C; Hornigold N; Astuti D; Cohen D; Maher ER; Stanley AJ; Harnden P; Joyce A; Knowles M; Selby PJ
Cancer Res; 2006 Feb; 66(4):2000-11. PubMed ID: 16488999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
